Lawsuit funding is NO LONGER AVAILABLE on Fosamax
What is Fosamax?
Fosamax (Alendronate) is prescribed to men and women for the prevention or treatment of osteoporosis and other bone diseases. Fosamax is manufactured by Merck & Company and received FDA approval in 1995. Since 2008, generic versions of this drug, called Alendronate, manufactured by Barr Pharmaceuticals and Teva Pharmaceuticals, have been available on the market.
The idea behind the drug is that it should reduce the risk of broken bones and fractures in patients. Unfortunately, and herein lies the problem, it is known for occasionally causing the opposite effect: It is known to cause serious femur fractures, along with other broken bones. Additionally, it has been reported that Fosamax might cause other serious medical conditions such as osteromyeltitis, which is the inflammation of bone marrow, and dead jaw disease (osteonecrosis).
Over the last several years, thousands of people have filed lawsuits when health complications emerged after they began taking the drug.
Medical experts have amassed overwhelming evidence that links the drug to thigh bone fractures resulting from little to no force being exerted to the bone.
The FDA encouraged Merck to add label warnings about bone fractures, but it took Merck over a year to include fractures as one of the possible side effects.
The active ingredient is Alendronic Acid. The medicine is considered a success and is, in fact, still available for sale and many post-menopausal women who used the drug have experienced improvement with regards to osteoporosis.
Side effects are very serious and those injured by them can claim just compensation.